SW
IBB icon

SlateStone Wealth’s iShares Biotechnology ETF IBB Stock Holding History

SlateStone Wealth’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Sell
2,180
-500
-19% -$85.9K 0.03% 236
2026
Q1 		$453K Sell
2,680
-300
-10% -$51.3K 0.04% 222
2025
Q4 		$503K Sell
2,980
-440
-13% -$71.5K 0.04% 216
2025
Q3 		$494K Sell
3,420
-2,370
-41% -$324K 0.04% 213
2025
Q2 		$732K Sell
5,790
-120
-2% -$14.7K 0.07% 176
2025
Q1 		$756K Sell
5,910
-390
-6% -$52.9K 0.08% 169
2024
Q4 		$833K Sell
6,300
-15,241
-71% -$2.14M 0.08% 169
2024
Q3 		$3.14M Sell
21,541
-170
-0.8% -$24.6K 0.28% 82
2024
Q2 		$2.98M Sell
21,711
-500
-2% -$66.7K 0.32% 74
2024
Q1 		$3.05M Sell
22,211
-4,145
-16% -$566K 0.31% 77
2023
Q4 		$3.58M Buy
26,356
+906
+4% +$111K 0.46% 59
2023
Q3 		$3.11M Sell
25,450
-1,000
-4% -$127K 0.45% 59
2023
Q2 		$3.36M Buy
26,450
+885
+3% +$115K 0.63% 36
2023
Q1 		$3.3M Hold
25,565
– – 0.68% 35
2022
Q4 		$3.36M Hold
25,565
– – 0.81% 30
2022
Q3 		$2.99M Sell
25,565
-50
-0.2% -$6.21K 0.8% 31
2022
Q2 		$3.01M Hold
25,615
– – 0.77% 30
2022
Q1 		$3.34M Sell
25,615
-710
-3% -$92.5K 0.74% 32
2021
Q4 		$4.02M Buy
26,325
+1,050
+4% +$163K 0.86% 29
2021
Q3 		$4.09M Hold
25,275
– – 0.94% 27
2021
Q2 		$4.14M Hold
25,275
– – 0.95% 27
2021
Q1 		$3.81M Sell
25,275
-150
-0.6% -$23.8K 0.94% 26
2020
Q4 		$3.85M Sell
25,425
-155
-0.6% -$22.2K 0.96% 27
2020
Q3 		$3.46M Hold
25,580
– – 0.75% 45
2020
Q2 		$3.5M Buy
25,580
+530
+2% +$67.6K 0.78% 32
2020
Q1 		$2.7M Sell
25,050
-300
-1% -$34.5K 0.77% 37
2019
Q4 		$3.06M Sell
25,350
-525
-2% -$58.6K 0.7% 42
2019
Q3 		$2.58M Sell
25,875
-2,050
-7% -$215K 0.75% 34
2019
Q2 		$3.05M Sell
27,925
-6,000
-18% -$638K 0.86% 32
2019
Q1 		$3.79M Hold
33,925
– – 1.16% 26
2018
Q4 		$3.27M Buy
+33,925
New +$3.6M 1.5% 17

Other funds holding IBB

GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

SlateStone Wealth's IBB Position: Q2 2026 in Review

SlateStone Wealth reduced its iShares Biotechnology ETF (IBB) stake by 19% in Q2 2026, selling an estimated $85.9K and leaving 2,180 shares worth $415K. The position accounts for 0.03% of the portfolio, ranked #236.

SlateStone Wealth first reported a position in IBB in Q4 2018 and has held it in 31 quarters since. The position peaked at $4.14M in Q2 2021. 201 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • SlateStone Wealth held 2,180 shares of iShares Biotechnology ETF worth $415K as of Q2 2026.
  • SlateStone Wealth sold 500 iShares Biotechnology ETF shares in Q2 2026, an estimated $85.9K.
  • iShares Biotechnology ETF made up 0.03% of SlateStone Wealth's portfolio in Q2 2026, its #236 holding.
  • SlateStone Wealth first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 31 quarters since.
  • SlateStone Wealth's iShares Biotechnology ETF position peaked at $4.14M in Q2 2021.
  • 201 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.